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INTRODUCTORY PARAGRAPH
To identify genetic variants associated with birth weight, we meta-analyzed six genome-wide
association (GWA) studies (N=10,623 Europeans from pregnancy/birth cohorts) and followed up
two lead signals in thirteen replication studies (N=27,591). Rs900400 near LEKR1 and CCNL1
(P=2×10−35), and rs9883204 in ADCY5 (P=7×10−15) were robustly associated with birth weight.
Correlated SNPs in ADCY5 were recently implicated in regulation of glucose levels and type 2
diabetes susceptibility,1 providing evidence that the well described association between lower
birth weight and subsequent type 2 diabetes2,3 has a genetic component, distinct from the
proposed role of programming by maternal nutrition. Using data from both SNPs, the 9% of
Europeans with 4 birth weight-lowering alleles were, on average, 113g (95%CI 89-137g) lighter at
birth than the 24% with 0 or 1 allele (Ptrend=7×10−30). The impact on birth weight is similar to that
of a mother smoking 4-5 cigarettes per day in the third trimester of pregnancy.4
The extremes of birth weight are associated with high risks of perinatal morbidity and
mortality.5,6 In addition, there are well-documented observational associations between
lower birth weight and later life chronic disease, including type 2 diabetes, cardiovascular
disease and higher blood pressure.2,3 The mechanisms underlying these associations are
poorly understood. Birth weight is a complex multifactorial trait.7,8 The importance of
genetic factors acting independently of the intra-uterine environment is illustrated by
correlations between paternal height or weight and offspring birth weight,7,9,10 and genetic
variants that are associated both with low birth weight and increased risk of type 2 diabetes
may account for some of the observed correlation between these phenotypes.11-13 However,
the genetic loci that influence birth weight are largely unknown.
Birth weight may be influenced directly by fetal genotype, and also indirectly by maternal
genotype operating through the intra-uterine environment. This is clearly illustrated by
observations of mothers and offspring with rare, heterozygous glucokinase (GCK)
mutations. By reducing insulin secretion, these mutations increase offspring birth weight by
600g when inherited by the mother and reduce birth weight by 530g when inherited by the
fetus.14
To search for common genetic variants associated with birth weight, we performed a meta-
analysis of GWA studies. We reasoned that finding such variants, even those with modest
effects, would lead to enhanced understanding of pathways important for fetal growth and
those underlying the associations between fetal growth and adult disease.
We meta-analyzed association statistics from 2,427,548 directly-genotyped and imputed
SNPs in singletons of European descent from six discovery GWA studies (N=10,623;
Supplementary Table 1). Birth weight (BW) was standardized to Z-scores within each study
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([BW-mean]/standard deviation, SD) and adjusted for sex and gestational age. We observed
SNPs at two independent loci on chromosome 3 that were associated with birth weight at, or
close to, genome-wide significance (P<5×10−8; Supplementary Figure 1). The first locus
was at 3q25, between CCNL1 and LEKR1; and the second, at 3q21 in ADCY5 (Figure 1).
To replicate these associations, we genotyped the most strongly associated SNP from each
locus (rs900400 from 3q25; rs9883204 from 3q21), or a closely-correlated proxy (HapMap
r2=0.927-0.963), in thirteen further samples of European descent (N=27,591; Supplementary
Table 2). Robust evidence of association was seen for both signals in these replication
samples (Figure 2; P=3×10−26 and 3×10−9, respectively). Combining all discovery and
replication samples, each additional C-allele of SNP rs900400 (frequency 32-47%) was
associated with a 0.086 SD lower birth weight (95%CI: 0.073-0.100; P=2×10−35), while
each C-allele of SNP rs9883204 (frequency 71-83%) was associated with a 0.063 SD lower
birth weight (95%CI: 0.047-0.079; P=7×10−15; Table 1). These SD changes equate
approximately to differences of 40g and 30g per allele, respectively (median study
SD=484g). Analysis conditional on the index SNPs, rs900400 and rs9883204 did not
produce any evidence for additional independent signals at either of the loci.
We found no evidence of heterogeneity between the studies examined (P>0.5; I2=0%),15
despite differences in mean birth weight (reflecting secular and population differences in
birth weight distribution; Table 2), and the associations with birth weight were similar in
males and females (P>0.05 for difference in effect sizes). Gestational age was not available
as a covariate in three of our replication studies (combined N=6235; Supplementary Table
2), but these studies did not introduce detectable heterogeneity, and their removal from the
meta-analysis changed the results very little (Figure 2 and Table 1 footnote). We also
assessed the effects of the two SNPs on birth weight in a limited number of non-European or
admixed samples from 2 studies (N=1415 Filipino subjects from the Cebu Longitudinal
Health and Nutrition Survey, and N=298-448 African descended, Moroccan and Turkish
subjects from Generation R; Supplementary Tables 2 and 3). There was no difference in the
effect sizes observed relative to the European studies (P>0.5), but power to detect
association was limited. Further well-powered studies will be needed to investigate these
associations in non-Europeans.
Maternal and fetal genotypes are correlated due to segregation. In a previous study, an
observed association between fetal TCF7L2 genotype and birth weight was driven by the
effects of maternal TCF7L2 variation on the intra-uterine environment, rather than a direct
effect on fetal growth.16 To distinguish between these two mechanisms, we tested whether
the novel birth weight associations were independent of maternal genotype. We genotyped
both SNPs in all available maternal DNAs (N=9127; 5 study samples). Meta-analysis of
associations between birth weight and fetal genotype, conditional on maternal genotype,
yielded results which were very similar to the original associations at both loci
(Supplementary Table 4), showing that these are direct fetal effects. As expected, there was
no association between fetal genotype and various covariates of birth weight that were not
included in our main analysis (maternal smoking, BMI, parity, education, age at delivery; all
P>0.05; data not shown).
Birth weight may be influenced by skeletal growth or fat mass. In available samples, we
analyzed the association between each locus and birth length, birth head circumference and
ponderal index (Table 1 and Supplementary Figures 2-4). The association with ponderal
index, relative to the birth length and head circumference associations, was particularly
strong for the rs900400 SNP (0.094 SD [95%CI: 0.074-0.113] per C-allele; P=5×10−21),
suggesting a greater association with fat mass than skeletal growth. For the rs9883204 SNP,
the measures showed more proportionate changes (Table 1). We investigated associations
with adult height and BMI using published GWA meta-analyses from the GIANT
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consortium.17,18 Only the rs900400 signal was captured in the published height data at
r2>0.8 (since that study only included direct genotypes from the Affymetrix Genechip
500k), and there was no association (P=0.64; N=9818). There was no association with adult
BMI for either locus (N≈32500, P>0.1). This is consistent with the weak observational
association between birth weight and adult BMI,19 indicating that they are largely governed
by different processes.
Although birth weight is a continuous trait, standard clinical cut-offs are used to identify
neonates who are small for gestational age and who may require further observation. We
therefore assessed whether each SNP increased the odds of gestational age-adjusted birth
weight <10th percentile. Both loci were associated with smallness for gestational age: odds
ratios (OR) 1.16 [95%CI: 1.10-1.23] (P=1×10−7) and 1.09 [1.02-1.16] (P=0.009) per C-
allele of rs900400 and rs9883204, respectively (Table 1; Supplementary Figure 5).
The birth weight signal marked by rs900400 maps approximately 35kb 3-prime to the
leucine, glutamate and lysine rich 1 (LEKR1) locus and 67kb 3-prime to cyclin L1
(CCNL1). Neither gene has previously been implicated in fetal growth. The CCNL1 protein
may be involved in pre-mRNA splicing and RNA processing, and associates with cyclin-
dependent kinases.20 A non-coding RNA of unknown function, 682bp from rs900400
(AK311218, Human March 2006 Assembly 18), overlaps with the signal. We found no
evidence for association at a genome-wide level (P>5×10−8) between our 3q25 birth weight
signal and mRNA expression in lymphocytes, using the publicly available ‘mRNA by SNP
Browser 1.0’,21 and there was no association between rs900400 or rs900399 and type 2
diabetes or related adult glycemic traits in the recent GWA meta-analysis from the MAGIC
consortium (P>0.1).1 A range of approaches (including resequencing and functional studies)
will be required to establish which gene (CCNL1, LEKR1 or another gene) is mediating the
effect on fetal growth.
The second birth weight locus at 3q21 (index SNP rs9883204) maps within the adenylyl
cyclase 5 gene (ADCY5). ADCY5 belongs to the family of enzymes responsible for the
synthesis of cyclic adenosine monophosphate (cAMP).22-24 Allele A of rs11708067, in
linkage disequilibrium (LD) with the birth weight-lowering C-allele of rs9883204 (r2=0.75),
is associated with a higher risk of type 2 diabetes (OR: 1.12 [95%CI: 1.04-1.15];
P=9.9×10−21; 40,655 cases/87,022 controls), higher fasting glucose (0.027 mmol/l [95%CI:
0.021-0.033]; P=7.1×10−22; N=118,475), and reduced values of the Homeostatic Model
Assessment (HOMA-) derived index of beta-cell function (HOMA-B; P=7.1×10−12;
N=94,212),1 suggesting that it may impact on insulin secretion. Fetal insulin is a key fetal
growth factor, and these metabolic associations suggest that one mechanism explaining the
ADCY5 association with birth weight might be a direct effect of the fetal risk allele on fetal
growth via reduced insulin secretion, consistent with the fetal insulin hypothesis.11
However, our previous studies suggest that an association between fetal genotype and birth
weight is not characteristic of all type 2 diabetes loci. For example, susceptibility variants at
CDKN2A/B, IGF2BP2 and SLC30A8 and TCF7L2 were not associated with birth weight in
previous studies of N>15000, after adjusting for maternal genotype.12,16 To test this more
comprehensively, we examined the associations between birth weight and all published type
2 diabetes (N=24) and fasting glucose (N=16) loci in our discovery GWA meta-analysis
(N=10,623).1,25,26 Only ADCY5 and the previously observed birth weight association at
CDKAL112,13 showed evidence of association at P<0.01 (Supplementary Table 5). One
explanation for the variable effects of different type 2 diabetes susceptibility loci on birth
weight is that they may influence beta-cell function at different points of the life course,
with ADCY5 having a more marked effect in utero than the other loci. However, other
mechanisms could be partially or wholly responsible for the ADCY5 association with birth
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weight including the regulation of placental glucose transporter expression,27 vitamin B2
uptake in the placenta28 and the architecture and permeability of the materno-fetal placental
barrier.29
The associations at 3q25 and 3q21 explained 0.3% and 0.1% of the variance in birth weight,
respectively. Given that estimates of the fetal genetic contribution to birth weight from twin
and family studies are generally between 10 and 40%,30,31 the proportion of heritability
explained may be up to ten times greater. The variance explained by the first locus is
comparable to that of maternal age (0.5%). We used a weighted risk allele score to estimate
the differences in birth weight attributable to combinations of birth weight-lowering alleles
at both loci. The 9% of Europeans with 4 birth weight-lowering alleles were, on average,
113g (95%CI 89-137g) lighter at birth than the 24% with 0 or 1 allele (P for trend
=7×10−30). For comparison, this effect on birth weight is similar to the impact of a mother
smoking 4-5 cigarettes per day,4 and is approximately one-third of the impact of the severe
malnutrition of the Dutch Famine of 1944-45, during which pregnant women consumed, on
average, <1000 calories/day.32
To conclude, we have identified novel, robust associations between fetal genotype and birth
weight at loci near CCNL1 and at ADCY5. The causal mechanisms are not yet known, but
the ADCY5 locus has pleiotropic effects on glucose regulation and type 2 diabetes in
adulthood. This is robust evidence that the widely described association between lower birth
weight and subsequent type 2 diabetes has a genetic component, distinct from the proposed
role of programming by maternal nutrition. Further understanding of these associations will
illuminate the biological pathways important for fetal growth and its relationship with adult
diseases.
METHODS
Stage 1: GWA meta-analysis of birth weight
Discovery samples, genotyping and imputation—We selected six population-based
European studies with birth weight, gestational age and GWA data available by the
beginning of May 2009 (combined N=10,623): the Northern Finland 1966 Birth Cohort
(NFBC1966; N=4333); Netherlands Twin Register (NTR; N=414; singletons only); and sub-
samples from the 1958 British Birth Cohort (B58C-WTCCC, N=1227; B58C-T1DGC,
N=2037), Generation R (N=1194) and Avon Longitudinal Study of Parents And Children
(ALSPAC; N=1418). The B58C-WTCCC and B58C-T1DGC were analyzed separately
because they were genotyped on different platforms at different times. However, there is no
systematic phenotypic difference between these sub-samples. Genotypes were obtained
using high-density SNP arrays, and then imputed for ~2.4 million HapMap SNPs (Phase II,
release 21/22, http://hapmap.ncbi.nlm.nih.gov/). The basic characteristics, exclusions (e.g.
samples of non-European ancestry), genotyping, quality control and imputation methods for
each discovery sample are presented in Supplementary Table 1.
Statistical analysis within discovery samples—Multiple and preterm births
(gestational age <37 weeks) were excluded from all analyses. Birth weight was transformed
into a Z-score (= [value-mean]/SD) to allow comparison of the data across studies. The
overall (as opposed to sex-stratified) mean and SD from each study were used to create Z-
scores. The association between each SNP and birth weight was assessed in each study
sample using linear regression of birth weight Z-score against genotype (additive model),
with sex and gestational age as covariates. Imputed genotypes were used only where
directly-assayed genotypes were unavailable. In addition to this “UNIFORM” analysis, a
second analysis (“BEST”) was performed, in which the analysis details were decided within
each study. Details of the BEST analysis, GWA analysis software, and any additional
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corrections for study-specific population structure in the UNIFORM analysis are given in
Supplementary Table 1.
Meta-analysis of discovery samples—Data exchange was facilitated by the
SIMBioMS platform (simbioms.org).33 Prior to meta-analysis, SNPs with a minor allele
frequency <1% and poorly-imputed SNPs (proper_info ≤0.4 [SNPTEST]; r2 ≤0.3
[MACH2QTL]) were filtered. Fixed effects meta-analyses of the UNIFORM and BEST
analyses were each run in parallel in two different study centers. Each was performed using
different software packages: METAL (http://www.sph.umich.edu/csg/abecasis/metal/
index.html); and MetaMapper (developed in-house at Imperial College London, UK).
Genomic control34 was applied twice at the meta-analysis stage: first, to adjust the statistics
generated within each cohort (see Supplementary Table 1 for individual study λ-values);
and second, to adjust the overall meta-analysis statistics (λ=1.032). The results from the
UNIFORM analysis were meta-analyzed using the inverse-variance method, whereas for the
BEST analysis a Z-score weighted method that allows for differences in the units of beta
coefficients and standard errors was applied.35 SNPs available for less than half of the total
expected sample were excluded. Final meta-analysis results were obtained for 2,427,548
SNPs. Those SNPs that reached a p-value threshold of <10−7 in the UNIFORM analysis
(N=10 SNPs, representing 2 distinct genomic regions on chromosome 3 were considered for
further follow-up. The UNIFORM (reported here) and BEST analyses (data not shown) gave
very similar results.
Checking for independent associations at the two loci—To test for the presence of
additional association signals around the most strongly associated SNP in each region
(rs900400 and rs9883204), we re-ran the UNIFORM association analysis on chromosome 3
in each discovery sample, including rs900400 and rs9883204 genotypes as additional
covariates. Where these SNPs were imputed, genotype dosage was calculated from the
genotype probabilities and used in the model. We meta-analyzed results using the inverse-
variance method.
Stage 2: Follow-up of two lead signals in additional samples
Follow-up samples, genotyping and analysis—We used 17 study samples
(combined N=30,098) to follow up the two lead signals from the GWA meta-analysis
(represented by index SNPs rs900400 and rs9883204). Details of these samples are
presented in Supplementary Table 2. Thirteen of the samples (combined N=27,591) were of
European ancestry and were used for replication of the birth weight associations. We also
examined associations in four further non-European or admixed study samples (combined
N=2507). Informed consent was obtained from all discovery and follow-up study
participants (or parental consent, as appropriate), and study protocols were approved by the
local ethics committees. If the index SNP was unavailable, a closely correlated proxy was
substituted (rs1482853 or rs900399 for rs900400 [HapMap r2=1 and 0.96, respectively];
rs2877716 or rs6798189 for rs9883204 [HapMap r2=0.95 and 0.93, respectively]). In four of
the replication studies, the index SNPs were imputed from genome-wide genotype data (see
Supplementary Table 2). The UNIFORM birth weight analysis (described above) was
performed within each study sample. To investigate whether the associations were similar in
the sexes, we repeated the analysis in males and females separately.
Meta-analyses—We performed fixed effects inverse variance meta-analyses of the
UNIFORM results as follows: (i) including all 13 European replication samples; (ii)
including all 19 discovery and replication samples of European descent, (iii) a sensitivity
analysis, excluding the three studies without gestational age; and (iv) including all 23 study
samples, regardless of ethnic background. We meta-analyzed the sex-stratified results from
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all European studies. All meta-analyses were performed in parallel at two different study
centers, using different software packages (the METAN module, developed for Stata v.10,36
MetaAnalyst [Beta 3.13],37 RMeta in R [v.2.7.0]). We used the Cochran Q test and the I2
statistic15 to assess evidence of between-study heterogeneity of effect sizes.
Analysis of additional phenotypes
Birth length, birth head circumference, ponderal index and small for
gestational age—Where available, we created Z-scores (value-mean/SD) within each
study for birth length, head circumference and ponderal index (birth weight/length3). We
used linear regression to assess the association between each outcome and each SNP
(rs900400 or rs9883204, or proxies), with sex and gestational age as covariates. To examine
the odds of small-for-gestational age (SGA), we created sex- and gestational age-adjusted
birth weight Z-scores (SDS) within 15 of the available European studies using Growth
Analyser 3.0 (http://www.growthanalyser.org; Dutch Growth Research Foundation,
Rotterdam, the Netherlands). The reference was a cohort of 475,588 children born between
1977 and 1981 in Sweden.38 Subsequently, each study defined SGA as below the 10th
percentile of birth weight SDS within their study population. We analysed the associations
between the two top hits and SGA using logistic regression. Analyses were repeated with a
5th percentile cut-off. We combined the results across studies using fixed effects inverse
variance meta-analysis.
Combined allele score
To estimate the birth weight effect sizes attributable to the two loci in combination, we
created an allele score using information from both SNPs, which was weighted by effect
size. This allowed us to estimate the differences in birth weight between individuals with
different numbers of birth weight-lowering alleles at the two loci. We used nine European
replication samples in which gestational age was available (N=20,190). After verifying that
the two SNPs were statistically independent, we generated the score using the formula
where sj is score for individual j, gij is number of birth weight-lowering alleles (0, 1, 2) for
SNP i carried by individual j and wi is effect size for SNP i from the UNIFORM analysis
within the cohort. We performed linear regression of birth weight (grams) against the allele
score (additive model), with sex and gestation as covariates. We combined the coefficients
from the nine studies using fixed effects inverse variance meta-analysis. We then rounded
the weighted score to the nearest integer, grouping scores “0” and “1” together, and
performed linear regression of birth weight against the rounded score as indicator variables,
with sex and gestation as covariates. The beta coefficients from the comparison of score 4
versus 0/1 in all nine studies were meta-analyzed (inverse variance, fixed effects).
Variance explained
To estimate the percentage of variation in birth weight explained by each of the associated
loci, we obtained the adjusted-R2 from univariate linear regression of birth weight against
genotype. We then calculated a mean value from all European studies, weighted by sample
size. For comparison, we also calculated the variance explained by variables such as
gestational age, maternal age and smoking.
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Analyses of potential confounders
To assess whether the associations were independent of maternal genotype, we used mother-
offspring pairs from the 5 studies with both maternal and fetal genotype available (see
Supplementary Table 4; total N=8880 for rs900400; N=9127 for rs9883204). Within each
study, we performed the UNIFORM analysis, with maternal genotype as an additional
covariate. For direct comparison, we repeated this without maternal genotype, using only
subjects for whom maternal genotype was available. We performed two inverse variance
meta-analyses (fixed effects) for each SNP, combining regression coefficients for (i) fetal
genotype, and (ii) fetal genotype adjusted for maternal genotype.
To verify that the SNPs were not associated with maternal covariates of birth weight which
could theoretically confound the observed associations with birth weight (including maternal
age, BMI, parity, smoking, pre-eclampsia, education), we used linear or logistic regression
to model the association between each covariate and genotype, using nine European
replication cohorts with gestational age available. Where possible, we meta-analyzed results
to assess overall evidence of association.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Regional plots of two novel associations with birth weight. For each of the two regions,
3q25 [A] and 3q21 [B], directly genotyped and imputed SNPs are plotted using filled circles
with their meta-analysis P values (as −log10 values) as a function of genomic position
(NCBI Build 35). In each plot, the discovery stage SNP taken forward to replication stage is
represented by a blue diamond (defining a global meta-analysis P value), with its discovery
meta-analysis P value denoted by a red diamond. Local LD structure is reflected by the
plotted estimated recombination rates (taken from HapMap) in the region around the
associated SNPs and their correlated proxies. Each analyzed SNP is represented by circle.
The colour scheme of the circles respects LD patterns (HapMap CEU pair-wise r2
correlation coefficients) between top discovery SNP and surrounding variants: white r2<0.2,
grey 0.5> r2 >= 0.2, orange 0.8> r2 >= 0.5, red r2 >= 0.8. Gene annotations were taken from
the University of California Santa Cruz genome browser.
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Figure 2.
Forest plots of the association between birth weight and genotype at each locus.
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[A] Index SNP rs900400 at 3q25.
[B] Index SNP rs9883204 at 3q21.
If the index SNP was unavailable, a closely-correlated proxy (HapMap r2>0.9) was used.
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